Panlor Tablets Dosage
Generic name: ACETAMINOPHEN 325mg, CAFFEINE 30mg, DIHYDROCODEINE BITARTRATE 16mg
Dosage form: tablet
Medically reviewed by Drugs.com. Last updated on Aug 31, 2020.
Important Dosage and Administration Instructions
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see WARNINGS].
Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see WARNINGS].
Monitor patients closely for respiratory depression, especially within the first 24-72 hours of initiating therapy and following dosage increases with PANLOR ® Tablets and adjust the dosage accordingly [see WARNINGS]
Initiating treatment with PANLOR ® Tablets
The usual adult dosage is two (2) PANLOR ® Tablets orally every four (4) hours, as needed. No more than five (5) doses, or ten (10) tablets should be taken in a 24-hour period.
Conversion from Other Opioids to PANLOR ® Tablets
There is inter-patient variability in the potency of opioid drugs and opioid formulations. Therefore, a conservative approach is advised when determining the total daily dosage of PANLOR ® Tablets. It is safer to underestimate a patient’s 24-hour PANLOR ® Tablets dosage than to overestimate the 24-hour PANLOR ® Tablets dosage and manage an adverse reaction due to overdose.
Titration and Maintenance of Therapy
Individually titrate PANLOR ® Tablets to a dose that provides adequate analgesia and minimizes adverse reactions. Continually reevaluate patients receiving PANLOR ® Tablets to assess the maintenance of pain control and the relative incidence of adverse reactions, as well as monitoring for the development of addiction, abuse, or misuse [see WARNINGS]. Frequent communication is important among the prescriber, other members of the healthcare team, the patient, and the caregiver/family during periods of changing analgesic requirements, including initial titration.
If the level of pain increases after dosage stabilization, attempt to identify the source of increased pain before increasing the PANLOR ® Tablets dosage. If unacceptable opioid-related adverse reactions are observed, consider reducing the dosage. Adjust the dosage to obtain an appropriate balance between management of pain and opioid-related adverse reactions.
Discontinuation of PANLOR ® Tablets
When a patient who has been taking PANLOR ® Tablets regularly and may be physically dependent no longer requires therapy with PANLOR ® Tablets, taper the dose gradually, by 25% to 50% every 2 to 4 days, while monitoring carefully for signs and symptoms of withdrawal. If the patient develops these signs or symptoms, raise the dose to the previous level and taper more slowly, either by increasing the interval between decreases, decreasing the amount of change in dose, or both. Do not abruptly discontinue PANLOR ® Tablets in a physically-dependent patient [see WARNINGS, DRUG ABUSE AND DEPENDENCE].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Panlor (acetaminophen / caffeine / dihydrocodeine)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- En Español
- Drug class: narcotic analgesic combinations
- FDA Alerts (2)